Structure-guided pharmacophore based virtual screening, docking, and molecular dynamics to discover repurposed drugs as novel inhibitors against endoribonuclease Nsp15 of SARS-CoV-2

References

• Abdul Samad, F., Suliman, B. A., Basha, S. H., Manivasagam, T., & Essa, M. M. (2016). A comprehensive in silico analysis on the structural and functional impact of SNPs in the congenital heart defects associated with NKX2-5 gene—A molecular dynamic simulation approach. PLoS One, 11(5), e0153999. https://doi.org/10.1371/journal.pone.0153999
   PubMed Web of Science ®Google Scholar
• Alam, S., & Khan, F. (2018). Virtual screening, docking, ADMET and system pharmacology studies on garcinia caged xanthone derivatives for anticancer activity. Scientific Reports, 8(1), 5524. https://doi.org/10.1038/s41598-018-23768-7
   PubMedGoogle Scholar
• Baby, S. T., Sharma, S., Enaganti, S., & Cherian, P. R. (2016). Molecular docking and pharmacophore studies of heterocyclic compounds as heat shock protein 90 (Hsp90) inhibitors. Bioinformation, 12(3), 149–155. https://doi.org/10.6026/97320630012149
   PubMed Web of Science ®Google Scholar
• Batool, A., Bibi, N., Amin, F., & Kamal, M. A. (2021). Drug designing against NSP15 of SARS-COV2 via high throughput computational screening and structural dynamics approach. European Journal of Pharmacology, 892, 173779. https://doi.org/10.1016/j.ejphar.2020.173779
   PubMed Web of Science ®Google Scholar
• Bickerton, G. R., Paolini, G. V., Besnard, J., Muresan, S., & Hopkins, A. L. (2012). Quantifying the chemical beauty of drugs. Nature Chemistry, 4(2), 90–98. https://doi.org/10.1038/nchem.1243
   PubMed Web of Science ®Google Scholar
• CDC. (2021). Coronavirus disease 2019 (COVID-19—Symptoms. centers for disease control and prevention. https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html
   Google Scholar
• Chandra, A., Gurjar, V., Qamar, I., & Singh, N. (2021). Identification of potential inhibitors of SARS-COV-2 endoribonuclease (EndoU) from FDA approved drugs: A drug repurposing approach to find therapeutics for COVID-19. Journal of Biomolecular Structure & Dynamics, 39(12), 4201–4211. https://doi.org/10.1080/07391102.2020.1775127
   PubMed Web of Science ®Google Scholar
• Chen, P.-Y., Tsai, C.-T., Ou, C.-Y., Hsu, W.-T., Jhuo, M.-D., Wu, C.-H., Shih, T.-C., Cheng, T.-H., & Chung, J.-G. (2012). Computational analysis of novel drugs designed for use as acetylcholinesterase inhibitors and histamine H3 receptor antagonists for Alzheimer's disease by docking, scoring and de novo evolution. Molecular Medicine Reports, 5(4), 1043–1048. https://doi.org/10.3892/mmr.2012.757
   PubMed Web of Science ®Google Scholar
• Choi, R., Zhou, M., Shek, R., Wilson, J. W., Tillery, L., Craig, J. K., Salukhe, I. A., Hickson, S. E., Kumar, N., James, R. M., Buchko, G. W., Wu, R., Huff, S., Nguyen, T.-T., Hurst, B. L., Cherry, S., Barrett, L. K., Hyde, J. L., & Voorhis, W. C. V. (2021). High-throughput screening of the ReFRAME, pandemic box, and COVID Box drug repurposing libraries against SARS-CoV-2 nsp15 endoribonuclease to identify small-molecule inhibitors of viral activity. PLoS One, 16(4), e0250019. https://doi.org/10.1371/journal.pone.0250019
   PubMed Web of Science ®Google Scholar
• Clark, R. D., Strizhev, A., Leonard, J. M., Blake, J. F., & Matthew, J. B. (2002). Consensus scoring for ligand/protein interactions. Journal of Molecular Graphics & Modelling, 20(4), 281–295. https://doi.org/10.1016/S1093-3263(01)00125-5
   PubMed Web of Science ®Google Scholar
• COVID Live—Coronavirus Statistics—Worldometer (n.d). Retrieved March 29, 2022, from. https://www.worldometers.info/coronavirus/
   Google Scholar
• De Clercq, E. (2004). Discovery and development of BVDU (brivudin) as a therapeutic for the treatment of herpes zoster. Biochemical Pharmacology, 68(12), 2301–2315. https://doi.org/10.1016/j.bcp.2004.07.039
   PubMed Web of Science ®Google Scholar
• Diallo, B. N., Swart, T., Hoppe, H. C., Tastan Bishop, Ö., & Lobb, K. (2021). Potential repurposing of four FDA approved compounds with antiplasmodial activity identified through proteome scale computational drug discovery and in vitro assay. Scientific Reports, 11(1), 1413. https://doi.org/10.1038/s41598-020-80722-2
   PubMed Web of Science ®Google Scholar
• Ding, X., Wu, Y., Wang, Y., Vilseck, J. Z., & Brooks, C. L. (2020). Accelerated CDOCKER with GPUs, parallel simulated annealing, and fast Fourier transforms. Journal of Chemical Theory and Computation, 16(6), 3910–3919. https://doi.org/10.1021/acs.jctc.0c00145
   PubMed Web of Science ®Google Scholar
• Gao, B., Gong, X., Fang, S., Weng, W., Wang, H., Chu, H., Sun, Y., Meng, C., Tan, L., Song, C., Qiu, X., Liu, W., Forlenza, M., Ding, C., & Liao, Y. (2021). Inhibition of anti-viral stress granule formation by coronavirus endoribonuclease nsp15 ensures efficient virus replication. PLoS Pathogens, 17(2), e1008690. https://doi.org/10.1371/journal.ppat.1008690
   PubMed Web of Science ®Google Scholar
• Glättli, A., Daura, X., & Gunsteren, W. F. V. (2003). A novel approach for designing simple point charge models for liquid water with three interaction sites. Journal of Computational Chemistry, 24(9), 1087–1096. https://doi.org/10.1002/jcc.10235
   PubMed Web of Science ®Google Scholar
• Hesse, S. E., Luethy, P. M., Beigel, J. H., & Zelazny, A. M. (2017). Penicillium citrinum: Opportunistic pathogen or idle bystander? A case analysis with demonstration of galactomannan cross-reactivity. Medical Mycology Case Reports, 17, 8–10. https://doi.org/10.1016/j.mmcr.2017.05.003
   PubMedGoogle Scholar
• Hong, S., Seo, S. H., Woo, S.-J., Kwon, Y., Song, M., & Ha, N.-C. (2021). Epigallocatechin gallate inhibits the uridylate-specific endoribonuclease Nsp15 and efficiently neutralizes the SARS-CoV-2 strain. Journal of Agricultural and Food Chemistry, 69(21), 5948–5954. https://doi.org/10.1021/acs.jafc.1c02050
   PubMed Web of Science ®Google Scholar
• Imming, P., Sinning, C., & Meyer, A. (2006). Drugs, their targets and the nature and number of drug targets. Nature Reviews: Drug Discovery, 5(10), 821–834. https://doi.org/10.1038/nrd2132
   PubMed Web of Science ®Google Scholar
• Ivanov, K. A., Hertzig, T., Rozanov, M., Bayer, S., Thiel, V., Gorbalenya, A. E., & Ziebuhr, J. (2004). Major genetic marker of nidoviruses encodes a replicative endoribonuclease. Proceedings of the National Academy of Sciences of the United States of America, 101(34), 12694–12699. https://doi.org/10.1073/pnas.0403127101
   PubMed Web of Science ®Google Scholar
• Jamal, Q. M. S., Lohani, M., Siddiqui, M. H., Haneef, M., Gupta, S. K., & Wadhwa, G. (2012). Molecular interaction analysis of cigarette smoke carcinogens NNK and NNAL with enzymes involved in DNA repair pathways: An in silico approach. Bioinformation, 8(17), 795–800. https://doi.org/10.6026/97320630008795
   PubMedGoogle Scholar
• Kang, H., Bhardwaj, K., Li, Y., Palaninathan, S., Sacchettini, J., Guarino, L., Leibowitz, J. L., & Kao, C. C. (2007). Biochemical and genetic analyses of murine hepatitis virus Nsp15 endoribonuclease. Journal of Virology, 81(24), 13587–13597. https://doi.org/10.1128/JVI.00547-07
   PubMed Web of Science ®Google Scholar
• Kim, Y., Jedrzejczak, R., Maltseva, N. I., Wilamowski, M., Endres, M., Godzik, A., Michalska, K., & Joachimiak, A. (2020). Crystal structure of Nsp15 endoribonuclease NendoU from SARS-CoV-2 . Protein Science: A Publication of the Protein Society, 29(7), 1596–1605. https://doi.org/10.1002/pro.3873
   PubMed Web of Science ®Google Scholar
• Kim, Y., Wower, J., Maltseva, N., Chang, C., Jedrzejczak, R., Wilamowski, M., Kang, S., Nicolaescu, V., Randall, G., Michalska, K., & Joachimiak, A. (2021). Tipiracil binds to uridine site and inhibits Nsp15 endoribonuclease NendoU from SARS-CoV-2. Communications Biology, 4(1) https://doi.org/10.1038/s42003-021-01735-9
   Google Scholar
• Kollman, P. A., Massova, I., Reyes, C., Kuhn, B., Huo, S., Chong, L., Lee, M., Lee, T., Duan, Y., Wang, W., Donini, O., Cieplak, P., Srinivasan, J., Case, D. A., & Cheatham, T. E. (2000). Calculating structures and free energies of complex molecules: Combining molecular mechanics and continuum models. Accounts of Chemical Research, 33(12), 889–897. https://doi.org/10.1021/ar000033j
   PubMed Web of Science ®Google Scholar
• Krammer, A., Kirchhoff, P. D., Jiang, X., Venkatachalam, C. M., & Waldman, M. (2005). LigScore: A novel scoring function for predicting binding affinities. Journal of Molecular Graphics & modelling, 23(5), 395–407. https://doi.org/10.1016/j.jmgm.2004.11.007
   PubMed Web of Science ®Google Scholar
• Kurczab, R., & Bojarski, A. J. (2013). New strategy for receptor-based pharmacophore query construction: A case study for 5-HT7 receptor ligands. Journal of Chemical Information and Modeling, 53(12), 3233–3243. https://doi.org/10.1021/ci4005207
   PubMed Web of Science ®Google Scholar
• Lai, C.-C., Shih, T.-P., Ko, W.-C., Tang, H.-J., & Hsueh, P.-R. (2020). Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. International Journal of Antimicrobial Agents, 55(3), 105924. https://doi.org/10.1016/j.ijantimicag.2020.105924
   PubMed Web of Science ®Google Scholar
• Li, Y., Su, M., Liu, Z., Li, J., Liu, J., Han, L., & Wang, R. (2018). Assessing protein-ligand interaction scoring functions with the CASF-2013 benchmark. Nature Protocols, 13(4), 666–680. https://doi.org/10.1038/nprot.2017.114
   PubMed Web of Science ®Google Scholar
• Michele, C., Maria, A. R. D. G., & Giovanni, N. R. (2020). SARS-CoV-2: Recent reports on antiviral therapies based on lopinavir/ritonavir, darunavir/umifenovir, hydroxychloroquine, remdesivir, favipiravir and other drugs for the treatment of the new coronavirus. Current Medicinal Chemistry, 27(27), 4536–4541.
   PubMed Web of Science ®Google Scholar
• Motwalli, O., & Alazmi, M. (2021). Analysis of natural compounds against the activity of SARS-CoV-2 NSP15 protein towards an effective treatment against COVID-19: A theoretical and computational biology approach. Journal of Molecular Modeling, 27(6), 160. https://doi.org/10.1007/s00894-021-04750-z
   PubMed Web of Science ®Google Scholar
• New coronavirus protein reveals drug target (n.d.). Retrieved May 28, 2021, from. https://news.northwestern.edu/stories/2020/03/new-coronavirus-protein-reveals-drug-target/
   Google Scholar
• Ortiz-Alcantara, J., Bhardwaj, K., Palaninathan, S., Frieman, M., Baric, R. S., & Kao, C. C. (2010). Small molecule inhibitors of the SARS-CoV Nsp15 endoribonuclease. Virus Adaptation and Treatment, 2, 125–133. https://doi.org/10.2147/VAAT.S12733
   Google Scholar
• Overington, J. P., Al-Lazikani, B., & Hopkins, A. L. (2006). How many drug targets are there? Nature Reviews: Drug Discovery, 5(12), 993–996. https://doi.org/10.1038/nrd2199
   PubMed Web of Science ®Google Scholar
• Pal, M., Berhanu, G., Desalegn, C., & Kandi, V. (n.d). Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): An update. Cureus, 12(3) https://doi.org/10.7759/cureus.7423
   Google Scholar
• Pal, S., Kumar, V., Kundu, B., Bhattacharya, D., Preethy, N., Reddy, M. P., & Talukdar, A. (2019). Ligand-based pharmacophore modeling, virtual screening and molecular docking studies for discovery of potential topoisomerase I Inhibitors. Computational and Structural Biotechnology Journal, 17, 291–310. https://doi.org/10.1016/j.csbj.2019.02.006
   PubMed Web of Science ®Google Scholar
• Prajapat, M., Sarma, P., Shekhar, N., Avti, P., Sinha, S., Kaur, H., Kumar, S., Bhattacharyya, A., Kumar, H., Bansal, S., & Medhi, B. (2020). Drug targets for corona virus: A systematic review. Indian Journal of Pharmacology, 52(1), 56–65. https://doi.org/10.4103/ijp.IJP_115_20
   PubMed Web of Science ®Google Scholar
• Pronk, S., Páll, S., Schulz, R., Larsson, P., Bjelkmar, P., Apostolov, R., Shirts, M. R., Smith, J. C., Kasson, P. M., van der Spoel, D., Hess, B., & Lindahl, E. (2013). GROMACS 4.5: A high-throughput and highly parallel open source molecular simulation toolkit. Bioinformatics (Oxford, England), 29(7), 845–854. https://doi.org/10.1093/bioinformatics/btt055
   PubMed Web of Science ®Google Scholar
• Rogers, D., & Hopfinger, A. J. (1994). Application of genetic function approximation to quantitative structure-activity relationships and quantitative structure-property relationships. Journal of Chemical Information and Computer Sciences, 34(4), 854–866. https://doi.org/10.1021/ci00020a020
   Google Scholar
• Şahin, Ş., Boado-Penas, M. d C., Constantinescu, C., Eisenberg, J., Henshaw, K., Hu, M., Wang, J., & Zhu, W. (2020). First quarter chronicle of COVID-19: An attempt to measure governments’ responses. Risks, 8(4), 115. https://doi.org/10.3390/risks8040115
   Web of Science ®Google Scholar
• Sahoo, B. M., Ravi Kumar, B. V. V., Sruti, J., Mahapatra, M. K., Banik, B. K., & Borah, P. (2021). Drug repurposing strategy (DRS): Emerging approach to identify potential therapeutics for treatment of novel coronavirus infection. Frontiers in Molecular Biosciences, 8, 628144. https://doi.org/10.3389/fmolb.2021.628144
   PubMed Web of Science ®Google Scholar
• Savale, R. U., Bhowmick, S., Osman, S. M., Alasmary, F. A., Almutairi, T. M., Abdullah, D. S., Patil, P. C., & Islam, M. A. (2021). Pharmacoinformatics approach based identification of potential Nsp15 endoribonuclease modulators for SARS-CoV-2 inhibition. Archives of Biochemistry and Biophysics, 700, 108771. https://doi.org/10.1016/j.abb.2021.108771
   PubMed Web of Science ®Google Scholar
• Schüttelkopf, A. W., & van Aalten, D. M. F. (2004). PRODRG: A tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallographica: Section D, Biological Crystallography, 60(Pt 8), 1355–1363. https://doi.org/10.1107/S0907444904011679
   PubMedGoogle Scholar
• Shahbaaz, M., Nkaule, A., & Christoffels, A. (2019). Designing novel possible kinase inhibitor derivatives as therapeutics against Mycobacterium tuberculosis: An in silico study. Scientific Reports, 9(1), 4405. https://doi.org/10.1038/s41598-019-40621-7
   PubMed Web of Science ®Google Scholar
• Singh, S., & Srivastava, P. (2014). Combined 3D QSAR based virtual screening and molecular docking study of some selected PDK-1 kinase inhibitors. Journal of Computational Medicine, 2014, e563080–12. https://doi.org/10.1155/2014/563080
   Google Scholar
• Wang, H., Li, X., Li, T., Zhang, S., Wang, L., Wu, X., & Liu, J. (2020). The genetic sequence, origin, and diagnosis of SARS-CoV-2. European Journal of Clinical Microbiology & Infectious Diseases, 39(9), 1629–1635. https://doi.org/10.1007/s10096-020-03899-4
   PubMed Web of Science ®Google Scholar
• Wang, R., Lu, Y., & Wang, S. (2003). Comparative evaluation of 11 scoring functions for molecular docking. Journal of Medicinal Chemistry, 46(12), 2287–2303. https://doi.org/10.1021/jm0203783
   PubMed Web of Science ®Google Scholar